✦ LIBER ✦

Pharmacokinetics and pharmacodynamics of a novel orally active angiotensin converting enzyme inhibitor (HOE 498) in healthy subjects

✍ Scribed by P. U. Witte; R. Irmisch; P. Hajdú; H. Metzger

Publisher: Springer
Year: 1984
Tongue: English
Weight: 446 KB
Volume: 27
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00556895

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjects

✍ Ulf G. Eriksson; Ulf Bredberg; Kristina Gislén; Linda C. Johansson; Lars Frison; 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 291 KB

Disposition of pentopril, a new orally a

Disposition of pentopril, a new orally active angiotensin-converting enzyme inhibitor, and its active metabolite in rats

✍ Ashok Rakhit; Gregory Kochak; Ronald Dotson; Vijay Tipnis 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 622 KB

The disposition characteristics of pentopril (the ethyl ester) and its active carboxylic acid metabolite (CGS 13934) were determined in conscious rats after separate intravenous administrations of both compounds. The relationship between plasma concentration and pharmacological effect was also evalu

The absence of a pharmacokinetic interac

The absence of a pharmacokinetic interaction between aspirin and the angiotensin-converting enzyme inhibitor benazepril in healthy volunteers

✍ A. Sioufi; F. Pommier; N. Gauducheau; J. Godbillon; L. Choi; V. John 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB 👁 2 views

Potential effects of the coadministration of single doses of aspirin (325mg) and of benazepril hydrochloride (20 mg) on the pharmacokinetics and the metabolism of these two drugs were evaluated in 12 healthy subjects. Plasma concentration profiles of benazepril, its active metabolite benazeprilat, a

Pharmacokinetics of the angiotensin conv

Pharmacokinetics of the angiotensin converting enzyme inhibitor benazepril·HCl (CGS 14 824 A) in healthy volunteers after single and repeated administration

✍ Dr. Günther Kaiser; Roland Ackermann; Sylvia Brechbühler; Walter Dieterle 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 577 KB

The pharmacokinetics of the new angiotensin converting enzyme (ACE) inhibitor benazeprikHC1 were evaluated in healthy male volunteers. The single dose kinetics were established from data of 62 subjects receiving an oral 10 mg dose of the drug. The steady state kinetics were investigated in 15 subjec

Effects of SQ 14.225, an orally active i

Effects of SQ 14.225, an orally active inhibitor of angiotensin-converting enzyme, on hypoxic pulmonary hypertension and right ventricular hypertrophy in rats

✍ D. Kentera; D. Sušić; A. Cvetković; Gordana Djordjević 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 400 KB

Bioavailability of repeated oral adminis

Bioavailability of repeated oral administration of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase in healthy volunteers

✍ P. Rousso; T. Buclin; J. Nussberger; F. Brunner-Ferber; H. R. Brunner; J. Biolla 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 112 KB